Major cash infusion: KKR is committing $300 million to FS KKR Capital via preferred stock purchases and a tender offer for common shares. Mounting financial strain: The fund posted a $560 million Q1 ...
Massive capital infusion: KKR will provide $600M through preferred stock, a tender offer, and buybacks to support FS KKR after a steep Q1 loss. Earnings and NAV hit: FS KKR’s Q1 loss widened to $1.57 ...